MF59™-adjuvanted seasonal influenza vaccine in young children

References

• Griffin MR, Walker FJ, Iwane MK, Weinberg GA, Staat MA, Erdman DD; New Vaccine Surveillance Network Study Group. Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network. Pediatr. Infect. Dis. J.23(11 Suppl.), S188–S192 (2004).
   PubMedGoogle Scholar
• Iwane MK, Edwards KM, Szilagyi PG et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics113(6), 1758–1764 (2004).
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Shay DK, Gershman K et al. Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003–2004. Pediatr. Infect. Dis. J.25(5), 395–400 (2006).
   PubMed Web of Science ®Google Scholar
• Dawood FS, Fiore A, Kamimoto L et al. Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. J. Pediatr.157(5), 808–814 (2010).
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N. Engl. J. Med.342(4), 225–231 (2000).
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E et al. Influenza-associated hospitalizations in the United States. JAMA292(11), 1333–1340 (2004).
   PubMed Web of Science ®Google Scholar
• Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N. Engl. J. Med.342(4), 232–239 (2000).
   PubMed Web of Science ®Google Scholar
• Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet358(9291), 1410–1416 (2001).
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S, Marchisio P, Gasparini R, Crovari P. Socioeconomic impact of influenza on healthy children and their families. Pediatr. Infect. Dis. J.22(10 Suppl.), S207–S210 (2003).
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Silvennoinen H, Peltola V et al. Burden of influenza in children in the community. J. Infect. Dis.190(8), 1369–1373 (2004).
   PubMed Web of Science ®Google Scholar
• Heinonen S, Silvennoinen H, Lehtinen P, Vainionpää R, Ziegler T, Heikkinen T. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect. Dis.11(1), 23–29 (2010).
   PubMedGoogle Scholar
• Poehling KA, Edwards KM, Weinberg GA et al. The underrecognized burden of influenza in young children. N. Engl. J. Med.355(1), 31–40 (2006).
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Weinberg GA, Bennett NM et al. Estimating the undetected burden of influenza hospitalizations in children. Epidemiol. Infect.135(6), 951–958 (2007).
   PubMed Web of Science ®Google Scholar
• Coffin SE, Zaoutis TE, Rosenquist AB et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics119(4), 740–748 (2007).
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Craig AS, Dupont WD et al. Estimating influenza hospitalizations among children. Emerg. Infect. Dis.12(1), 103–109 (2006).
   PubMed Web of Science ®Google Scholar
• Ampofo K, Gesteland PH, Bender J et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics118(6), 2409–2417 (2006).
   PubMed Web of Science ®Google Scholar
• Montes M, Vicente D, Pérez-Yarza EG, Cilla G, Pérez-Trallero E. Influenza-related hospitalisations among children aged less than 5 years old in the Basque Country, Spain: a 3-year study (July 2001–June 2004). Vaccine23(34), 4302–4306 (2005).
   PubMed Web of Science ®Google Scholar
• Rojo JC, Ruiz-Contreras J, Fernández MB, Marín MA, Folgueira L. Influenza-related hospitalizations in children younger than three years of age. Pediatr. Infect. Dis. J.25(7), 596–601 (2006).
   PubMed Web of Science ®Google Scholar
• Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin. Infect. Dis.36(3), 299–305 (2003).
   PubMed Web of Science ®Google Scholar
• Meury S, Zeller S, Heininger U. Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents. Eur. J. Pediatr.163(7), 359–363 (2004).
   PubMedGoogle Scholar
• Puig-Barberà J, Arnedo-Pena A, Pardo-Serrano F et al. Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study. Vaccine28(47), 7460–7467 (2010).
   PubMed Web of Science ®Google Scholar
• Proff R, Gershman K, Lezotte D, Nyquist AC. Case-based surveillance of influenza hospitalizations during 2004–2008, Colorado, USA. Emerg. Infect. Dis.15(6), 892–898 (2009).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza – United States, 1976–2007. MMWR Morb. Mortal. Wkly Rep.59(33), 1057–1062 (2010).
   PubMedGoogle Scholar
• Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA289(2), 179–186 (2003).
   PubMed Web of Science ®Google Scholar
• Bhat N, Wright JG, Broder KR et al. Influenza-associated deaths among children in the United States, 2003–2004. N. Engl. J. Med.353(24), 2559–2567 (2005).
   PubMed Web of Science ®Google Scholar
• Johnson BF, Wilson LE, Ellis J et al. Fatal cases of influenza A in childhood. PloS One4(10), 32–38 (2009).
   Google Scholar
• Cox CM, Blanton L, Dhara R, Brammer L, Finelli L. 2009 Pandemic influenza A (H1N1) deaths among children – United States, 2009–2010. Clin. Infect. Dis.52(Suppl. 1), S69–S74 (2011).
   PubMed Web of Science ®Google Scholar
• Fine P, Eames K, Heymann DL. ‘Herd immunity’: a rough guide. Clin. Infect. Dis.52(7), 911–916 (2011).
   PubMed Web of Science ®Google Scholar
• Brownstein JS, Kleinman KP, Mandl KD. Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. Am. J. Epidemiol.162(7), 686–693 (2005).
   PubMedGoogle Scholar
• Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PloS Med.4(8), e247 (2007).
   PubMedGoogle Scholar
• Mossong J, Hens N, Jit M et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PloS Med.5(3), e74 (2008).
   PubMed Web of Science ®Google Scholar
• Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N. Engl. J. Med.344(12), 889–896 (2001).
   PubMed Web of Science ®Google Scholar
• King JC, Stoddard JJ, Gaglani MJ et al. Effectiveness of school-based influenza vaccination. N. Engl. J. Med.355(24), 2523–2532 (2006).
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Zhu Y, Simonsen L, Mitchel E, Griffin MR. The population impact of a large school-based influenza vaccination campaign. PloS One5(11), e15097 (2010).
   PubMedGoogle Scholar
• Jordan R, Connock M, Albon E et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine24(8), 1047–1062 (2006).
   PubMed Web of Science ®Google Scholar
• Loeb M, Russell ML, Moss L et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA303(10), 943–950 (2010).
   PubMed Web of Science ®Google Scholar
• Small PA, Morris JG. Influenza vaccination of children and infection rates in the community. JAMA303(23), 2355–2356; author reply 2356 (2010).
   PubMedGoogle Scholar
• Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet365(9461), 773–780 (2005).
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst. Rev. (2), CD004879 (2008).
   PubMedGoogle Scholar
• Belshe RB, Edwards KM, Vesikari T et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med.356(7), 685–696 (2007).
   PubMed Web of Science ®Google Scholar
• Vesikari T. Emerging data on the safety and efficacy of influenza vaccines in children. Pediatr. Infect. Dis. J.27(11 Suppl.), S159–S161 (2008).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age. Vaccine26(Suppl. 4), D10–D16 (2008).
   PubMed Web of Science ®Google Scholar
• Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine27(49), 6959–6965 (2009).
   PubMed Web of Science ®Google Scholar
• Schultze V, D’Agosto V, Wack A, Novicki D, Zorn J, Hennig R. Safety of MF59 adjuvant. Vaccine26(26), 3209–3222 (2008).
   PubMed Web of Science ®Google Scholar
• O’Hagan DT. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection. Expert Rev. Vaccines6(5), 699–710 (2007).
   PubMed Web of Science ®Google Scholar
• Tsai TF, Crucitti A, Nacci P et al. Explorations of clinical trials and pharmacovigilance databases of MF59(®)-adjuvanted influenza vaccines for associated cases of narcolepsy. Scand. J. Infect. Dis.43(9), 702–706 (2011).
   PubMed Web of Science ®Google Scholar
• Mosca F, Tritto E, Muzzi A et al. Molecular and cellular signatures of human vaccine adjuvants. Proc. Natl Acad. Sci. USA105(30), 10501–10506 (2008).
   PubMed Web of Science ®Google Scholar
• Seubert A, Monaci E, Pizza M, O’Hagan DT, Wack A. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J. Immunol.180(8), 5402–5412 (2008).
   PubMed Web of Science ®Google Scholar
• Calabro S, Tortoli M, Baudner BC et al. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine29(9), 1812–1823 (2011).
   PubMed Web of Science ®Google Scholar
• Khurana S, Chearwae W, Castellino F et al. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci. Transl. Med.2(15), 15ra5 (2010).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Pellegrini M, Karvonen A et al. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr. Infect. Dis. J.28(7), 563–571 (2009).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Knuf M, Wutzler P et al. Efficacy of and mf59-adjuvanted seasonal influenza vaccine versus non-adjuvanted influenza vaccine and control vaccine in 6 to < 72 month children. Presented at: 48th IDSA Annual Meeting. Vancouver, Canada, 21–24 October 2010.
   Google Scholar
• Black S, Della Cioppa G, Malfroot A et al. Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: an integrated analysis. Vaccine28(45), 7331–7336 (2010).
   PubMed Web of Science ®Google Scholar
• Arora A, Tilman S, Papadopoulus A, Pfaff M. Safety profile of MF59-adjuvanted vaccine versus non-adjuvanred vaccines: pooled data from pediatric clinical trials. Presented at: 29th ESPID Meeting. The Hague, The Netherlands, 7–11 June 2011.
   Google Scholar
• Tsai TF, Knuf M, Wutzler P et al. Safety of an MF59-adjuvanted seasonal influenza vaccine in 6 to 24 month old children. Presented at: 29th ESPID Meeting. The Hague, The Netherlands, 7–11 June 2011.
   Google Scholar
• Banzhoff A, Haertel S, Praus M. Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations. Hum. Vaccin.7(5), 1–10 (2011).
   Google Scholar